Literature DB >> 34950566

Large adrenocortical adenoma with malignant features on imaging: A case report.

Shin Koike1, Shotaro Nakanishi1, Sunao Nohara1, Hirofumi Miyahira2, Tomoko Tamaki2, Seiichi Saito1.   

Abstract

Large adrenocortical adenomas have rarely been reported. We describe a case of a 26-year-old man who underwent an adrenalectomy for a large adrenocortical adenoma (8.6 × 7.7 cm). Although the lesion had typical malignant features on imaging, histopathological examination revealed an adrenocortical adenoma. This highlights that imaging alone may not be able to distinguish adrenocortical carcinomas from adrenal masses. In most cases, a resection should be performed for early diagnosis and management of large adrenal masses with malignant features on imaging. To our knowledge, this is the first report of a large adrenocortical adenoma diagnosed with multiple imaging investigations.
© 2021 The Authors.

Entities:  

Keywords:  18F-FDG PET/CT, F-18 fluorodeoxyglucose positron emission tomography/computed tomography; Adrenal incidentaloma; Adrenal mass; Adrenocortical adenoma; Adrenocortical carcinoma; CT, computed tomography; MRI, magnetic resonance imaging; SUVmax, maximum standardized uptake value

Year:  2021        PMID: 34950566      PMCID: PMC8671860          DOI: 10.1016/j.eucr.2021.101968

Source DB:  PubMed          Journal:  Urol Case Rep        ISSN: 2214-4420


Introduction

Adrenal masses are often classified as incidentalomas, because most are detected during the work-up for non-adrenal diseases. Most large adrenal masses are potentially malignant; benign large adrenal tumors have rarely been reported., Here, we report a rare case of a large adrenocortical adenoma presenting with some malignant radiologic features.

Case presentation

A 26-year-old man visited a general hospital for abdominal and left flank pain. Contrast-enhanced computed tomography (CT) confirmed the diagnosis of appendicitis. However, a left adrenal mass was incidentally identified, which prompted referral to our hospital for further investigation and treatment. Contrast-enhanced CT revealed an 8.6 × 7.7-cm, heterogeneously enhancing mass in the left suprarenal region with increased vascularity (Fig. 1a and b). Similarly, T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) revealed a hyperintense suprarenal mass (Fig. 1c).
Fig. 1

Radiologic findings. (a, b) Contrast-enhanced computed tomography revealing an 8.6 × 7.7-cm heterogeneously enhancing left suprarenal mass with increased vascularity. (c) T2-weighted magnetic resonance imaging showing a hyperintense left adrenal mass.

Radiologic findings. (a, b) Contrast-enhanced computed tomography revealing an 8.6 × 7.7-cm heterogeneously enhancing left suprarenal mass with increased vascularity. (c) T2-weighted magnetic resonance imaging showing a hyperintense left adrenal mass. All hormonal studies were negative. 123I-meta-iodobenzylguanidinescintigraphy showed no signs of a pheochromocytoma (Fig. 2a). F-18 fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) showed a strong uptake in the lesion, with a maximum standardized uptake value (SUVmax) of 21.39 (Fig. 2b and c).
Fig. 2

Imaging findings. (a) 123I-meta-iodobenzylguanidine scintigraphy showing no signs of a pheochromocytoma. (b, c) F-18 fluorodeoxyglucose positron emission tomography/computed tomography revealing strong uptake in the left adrenal region with a maximum standardized uptake value of 21.39.

Imaging findings. (a) 123I-meta-iodobenzylguanidine scintigraphy showing no signs of a pheochromocytoma. (b, c) F-18 fluorodeoxyglucose positron emission tomography/computed tomography revealing strong uptake in the left adrenal region with a maximum standardized uptake value of 21.39. A left open adrenalectomy was performed. Intraoperatively, the tumor had a relatively distinct margin with mild adhesions between the psoas muscle. The histopathologic findings were consistent with the diagnosis of an adrenocortical adenoma as the tumor did not meet any of the Weiss criteria (Fig. 3a, b, c, d). The patient's postoperative course was uneventful with resolution of the flank pain.
Fig. 3

Histopathological findings. (a) H&E staining (×100): section of the adrenocortical adenoma showing solid sheets and nests of acidophilic cells with large and small nuclei, Immunohistochemistry of the adrenocortical adenoma; (b) SF-1 (×100): positive; (c) alpha-inhibin (×100): positive; (d) Ki-67 (×100): low Ki-67-labeling proliferating index (1%–2%). H&E, Hematoxylin and eosin; SF-1, Steroidogenic factor 1.

Histopathological findings. (a) H&E staining (×100): section of the adrenocortical adenoma showing solid sheets and nests of acidophilic cells with large and small nuclei, Immunohistochemistry of the adrenocortical adenoma; (b) SF-1 (×100): positive; (c) alpha-inhibin (×100): positive; (d) Ki-67 (×100): low Ki-67-labeling proliferating index (1%–2%). H&E, Hematoxylin and eosin; SF-1, Steroidogenic factor 1.

Discussion

Incidentalomas are lesions that are detected during routine imaging investigations for other diseases. With the increasing use of radiologic techniques, the incidence of incidentalomas is increasing continuously. The size of the mass is correlated to its potential for malignancy. According to Mohamed et al., up to 70% of adrenal masses ≥4 cm were associated with malignancies. Among masses greater than 6 cm, 85% were malignant. Typical imaging features and sizes of adrenal masses are variable. In the present case, the tumor had typical characteristics of an adrenocortical carcinoma (i.e., heterogeneous on CT, hyperintense on T2-weighted MRI, and size ≥4 cm).2Furthermore, 18F-FDG PET/CT showed a strong uptake in the left adrenal region (SUVmax = 21.39). Although these features were highly suggestive of malignancy, the tumor did not fulfill the Weiss criteria. According to recent studies, 18F-FDGPET with or without CT had high sensitivity (91%) and specificity (91%); the positive and negative likelihood ratios were 9.9 and 0.09, respectively. Despite this diagnostic accuracy, the utility of these techniques for the characterization of adrenal masses remains limited. These modalities are not highly recommended for patients without a known malignant lesion. Resection is recommended for adrenal masses ≥4 cm. In this case, a left adrenalectomy was performed. Considering the lesion's typical malignant features, we expected a pathological diagnosis of an adrenocortical carcinoma. However, fortunately, the histopathologic findings were consistent with an adrenocortical adenoma.

Conclusion

Herein, we report a case of a large adrenocortical adenoma that radiographically presented as a malignancy. Ours is the first report of a large adrenocortical adenoma diagnosed with multiple imaging investigations. Our findings suggest that imaging may not adequately differentiate between adrenocortical carcinomas and incidentalomas. Adrenocortical adenomas presenting with malignant imaging features must be resected for early diagnosis and treatment.

Author contributions

Shin Koike, Shotaro Nakanishi; Conceptualization, Investigation, Writing - Original draft preparation, Writing - Reviewing and Editing. Sunao Nohara, Hiroshi Miyahira, and Tomoko Tamaki: Writing - Original draft preparation. Seiichi Saito: Supervision.

Consent

Written informed consent was obtained for the publication of this case report.

Declaration of interest

None.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
  5 in total

Review 1.  Clinical practice. The incidentally discovered adrenal mass.

Authors:  William F Young
Journal:  N Engl J Med       Date:  2007-02-08       Impact factor: 91.245

Review 2.  Management of incidental adrenal masses: an update.

Authors:  Daniel I Glazer; William W Mayo-Smith
Journal:  Abdom Radiol (NY)       Date:  2020-04

3.  On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes.

Authors:  H Hedeland; G Ostberg; B Hökfelt
Journal:  Acta Med Scand       Date:  1968-09

Review 4.  Diagnostic accuracy of 18F-FDG PET or PET/CT for the characterization of adrenal masses: a systematic review and meta-analysis.

Authors:  Seong-Jang Kim; Sang-Woo Lee; Kyoungjune Pak; In-Ju Kim; Keunyoung Kim
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

Review 5.  Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics.

Authors:  Mohamed G Elbanan; Sanaz Javadi; Dhakshinamoorthy Ganeshan; Mouhammed Amir Habra; Brinda Rao Korivi; Silvana C Faria; Khaled M Elsayes
Journal:  Abdom Radiol (NY)       Date:  2020-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.